StoneX Group
TPST icon

StoneX Group’s Tempest Therapeutics TPST Stock Holding History

StoneX Group’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$11.7K Buy
+13,668
New +$13.4K ﹤0.01% 1835

Other funds holding TPST

Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

StoneX Group's TPST Position: Q3 2026 in Review

StoneX Group opened a new position in Tempest Therapeutics (TPST) in Q3 2026: 13,668 shares worth $11.7K. The stake represents ﹤0.01% of the portfolio and ranks #1835 among its holdings.

5 funds tracked by Wall St. Rank hold TPST as of Q3 2026.

  • StoneX Group held 13,668 shares of Tempest Therapeutics worth $11.7K as of Q3 2026.
  • Tempest Therapeutics was a new StoneX Group position in Q3 2026.
  • Tempest Therapeutics made up ﹤0.01% of StoneX Group's portfolio in Q3 2026, its #1835 holding.
  • 5 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2026.

Based on StoneX Group's 13F filing for Q3 2026, filed 3 Nov 2026.